New Zealand markets close in 5 hours 33 minutes

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
104.82+1.86 (+1.81%)
At close: 04:02PM EDT
104.90 +0.08 (+0.08%)
After hours: 07:13PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 179.11B
Enterprise value 187.05B
Trailing P/E 32.07
Forward P/E 22.17
PEG ratio (5-yr expected) 5.61
Price/sales (ttm)4.46
Price/book (mrq)4.62
Enterprise value/revenue 4.64
Enterprise value/EBITDA 17.98

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-1.04%
S&P500 52-week change 329.31%
52-week high 3121.64
52-week low 389.67
50-day moving average 3109.06
200-day moving average 3106.24

Share statistics

Avg vol (3-month) 35.72M
Avg vol (10-day) 36.47M
Shares outstanding 51.74B
Implied shares outstanding 61.74B
Float 81.73B
% held by insiders 10.53%
% held by institutions 176.97%
Shares short (30 Apr 2024) 414.48M
Short ratio (30 Apr 2024) 42.74
Short % of float (30 Apr 2024) 40.84%
Short % of shares outstanding (30 Apr 2024) 40.83%
Shares short (prior month 28 Mar 2024) 414.48M

Dividends & splits

Forward annual dividend rate 42.2
Forward annual dividend yield 42.14%
Trailing annual dividend rate 32.12
Trailing annual dividend yield 32.06%
5-year average dividend yield 41.60
Payout ratio 464.80%
Dividend date 315 May 2024
Ex-dividend date 412 Apr 2024
Last split factor 210000:4798
Last split date 302 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.96%
Operating margin (ttm)15.40%

Management effectiveness

Return on assets (ttm)6.09%
Return on equity (ttm)14.76%

Income statement

Revenue (ttm)40.33B
Revenue per share (ttm)23.18
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 10.37B
Net income avi to common (ttm)5.61B
Diluted EPS (ttm)3.21
Quarterly earnings growth (yoy)-7.10%

Balance sheet

Total cash (mrq)6.65B
Total cash per share (mrq)3.82
Total debt (mrq)14.71B
Total debt/equity (mrq)37.66%
Current ratio (mrq)1.60
Book value per share (mrq)22.31

Cash flow statement

Operating cash flow (ttm)7.14B
Levered free cash flow (ttm)4.61B